21-Nov-2024 15:54 |
3.89p |
137,044 |
£5,331 |
Sell |
O |
21-Nov-2024 15:54 |
3.89p |
146,222 |
£5,688 |
Sell |
O |
21-Nov-2024 15:39 |
3.90p |
240,000 |
£9,360 |
Unknown |
O |
21-Nov-2024 13:26 |
3.90p |
130,000 |
£5,070 |
Unknown |
O |
21-Nov-2024 13:26 |
3.85p |
150,000 |
£5,778 |
Sell |
O |
21-Nov-2024 13:26 |
3.85p |
150,000 |
£5,778 |
Sell |
O |
21-Nov-2024 11:49 |
3.82p |
3,500 |
£134 |
Sell |
O |
21-Nov-2024 09:43 |
3.82p |
8,121 |
£310 |
Sell |
O |
21-Nov-2024 09:01 |
3.81p |
15,000 |
£572 |
Sell |
O |
21-Nov-2024 08:03 |
3.87p |
120,000 |
£4,644 |
Buy |
O |
21-Nov-2024 08:03 |
4.00p |
381,500 |
£15,260 |
Buy |
O |
21-Nov-2024 08:00 |
3.87p |
12,766 |
£494 |
Buy |
O |
15:54 |
137,044 @ 3.89p |
15:54 |
146,222 @ 3.89p |
15:39 |
240,000 @ 3.90p |
13:26 |
130,000 @ 3.90p |
13:26 |
150,000 @ 3.85p |
CFO |
Alexander John Abrey |
CEO |
Sean M. Smith |
Top of Page
You are here:
research